SEC EDGAR Filing Information

Form 10KSB -- Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]

Period of Report: 2007-12-31
Filing Date Changed: 2008-03-27
Documents: 6

SEC Accession No.
0000812796-08-000008
Filing date: 2008-03-27
Accepted: 2008-03-27 15:58:21

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10KSB	dor10k2007.htm	1253886	DOR 10 K 2007
2	EX-31.1	ceocert10k2007.htm	12753	CEO CERT
3	EX-31.2	cfocert10k2007.htm	12697	CFO CERT
4	EX-32.1	ceosox10k2007.htm	6616	CEO SOX CERT
5	EX-32.2	cfosox10k2007.htm	6587	CFO SOX CERT
6	EX-21.1	subsidiaries.htm	5505	SUBSIDIARIES

		0000812796-08-000008.txt	1299659	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-16929 | Film No.: 08715140
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628